Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles

BACKGROUND: Adoptive T cell therapy (ATCT) has been successful in treating hematological malignancies and is currently under investigation for solid-tumor therapy. In contrast to existing chimeric antigen receptor (CAR) T cell and/or antigen-specific T cell approaches, which require known targets, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, Elizabeth E., Sekhri, Palak, Telaraja, Deepti, Chen, Jie, Chin, Samantha J., Chiappinelli, Katherine B., Sanchez, Carlos E., Bollard, Catherine M., Cruz, C. Russell Y., Fernandes, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264146/
https://www.ncbi.nlm.nih.gov/pubmed/37278683
http://dx.doi.org/10.1016/j.jcyt.2023.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264146/
https://www.ncbi.nlm.nih.gov/pubmed/37278683
http://dx.doi.org/10.1016/j.jcyt.2023.03.014

Ejemplares similares